应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
HIMS Hims & Hers Health Inc.
盘后交易 03-30 16:14:21 EDT
18.78
-0.60
-3.10%
盘后
18.77
-0.01
-0.05%
16:14 EDT
最高
19.67
最低
18.62
成交量
1,905万
今开
19.35
昨收
19.38
日振幅
5.42%
总市值
42.75亿
流通市值
37.09亿
总股本
2.28亿
成交额
3.63亿
换手率
9.65%
流通股本
1.98亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Hims & Hers平台扩容:将引入Wegovy与Ozempic减重药物
美股速递 · 03-18
Hims & Hers平台扩容:将引入Wegovy与Ozempic减重药物
Hims & Hers Health(HIMS)盘前涨8% 日前与诺和诺德建立新的合作伙伴关系
金吾财讯 · 03-12
Hims & Hers Health(HIMS)盘前涨8% 日前与诺和诺德建立新的合作伙伴关系
盘前异动 | 石油股上涨,Battalion Oil涨近8%;HIMS续涨逾5%,本田汽车跌超8%
老虎资讯综合 · 03-12
盘前异动 | 石油股上涨,Battalion Oil涨近8%;HIMS续涨逾5%,本田汽车跌超8%
异动解读 | 与诺和诺德达成合作并获诉讼和解,Hims & Hers盘前大涨5.33%
异动解读 · 03-12
异动解读 | 与诺和诺德达成合作并获诉讼和解,Hims & Hers盘前大涨5.33%
异动解读 | 与诺和诺德达成合作并获诉讼和解,Hims & Hers夜盘大涨5.02%
异动解读 · 03-12
异动解读 | 与诺和诺德达成合作并获诉讼和解,Hims & Hers夜盘大涨5.02%
期权大单|甲骨文绩后飙升逾9%,期权成交量激增;利好叠加!Hims & Hers三日累涨逾64%,期权交投持续火热
老虎资讯综合 · 03-12
期权大单|甲骨文绩后飙升逾9%,期权成交量激增;利好叠加!Hims & Hers三日累涨逾64%,期权交投持续火热
夜盘异动|石油股走高,INDO大涨超14%,HIMS续涨1.5%
老虎资讯综合 · 03-12
夜盘异动|石油股走高,INDO大涨超14%,HIMS续涨1.5%
异动解读 | Hims & Hers Health盘中大涨5.16%,与诺和诺德达成合作并挖角礼来公关大将
异动解读 · 03-11
异动解读 | Hims & Hers Health盘中大涨5.16%,与诺和诺德达成合作并挖角礼来公关大将
Hims & Hers(HIMS.US)挖角礼来公关大将!剑指品牌减肥药新战场
智通财经 · 03-11
Hims & Hers(HIMS.US)挖角礼来公关大将!剑指品牌减肥药新战场
异动解读 | Hims & Hers Health盘中大涨13.37%,与诺和诺德达成合作协议并获花旗上调评级
异动解读 · 03-10
异动解读 | Hims & Hers Health盘中大涨13.37%,与诺和诺德达成合作协议并获花旗上调评级
Hims & Hers与诺和诺德达成和解
环球市场播报 · 03-10
Hims & Hers与诺和诺德达成和解
花旗集团上调Hims & Hers Health Inc评级至中性,目标价大幅提升至24美元
美股速递 · 03-10
花旗集团上调Hims & Hers Health Inc评级至中性,目标价大幅提升至24美元
异动解读 | 与诺和诺德达成合作协议,Hims & Hers Health盘前大涨5.14%
异动解读 · 03-10
异动解读 | 与诺和诺德达成合作协议,Hims & Hers Health盘前大涨5.14%
盘前异动 | 光通信股续涨,Coherent涨近4%; 福泰制药涨超5%,无人机概念股JOBY涨近5%
老虎资讯综合 · 03-10
盘前异动 | 光通信股续涨,Coherent涨近4%; 福泰制药涨超5%,无人机概念股JOBY涨近5%
花旗上调Hims & Hers Health(HIMS.US)评级至“中性” 看好诺和诺德协议下的合规溢价
智通财经 · 03-10
花旗上调Hims & Hers Health(HIMS.US)评级至“中性” 看好诺和诺德协议下的合规溢价
ETF日报|2倍做多Hims & Hers ETF涨超81%;三倍做多半导体ETF涨超11%;成长风格领跑
老虎资讯综合 · 03-10
ETF日报|2倍做多Hims & Hers ETF涨超81%;三倍做多半导体ETF涨超11%;成长风格领跑
期权大单|半导体板块全线反弹!英伟达看涨期权遭抢筹;Hims & Hers股价飙升逾40%,Call单最高涨84倍
老虎资讯综合 · 03-10
期权大单|半导体板块全线反弹!英伟达看涨期权遭抢筹;Hims & Hers股价飙升逾40%,Call单最高涨84倍
异动解读 | 与诺和诺德达成合作协议,Hims & Hers Health夜盘大涨5.64%
异动解读 · 03-10
异动解读 | 与诺和诺德达成合作协议,Hims & Hers Health夜盘大涨5.64%
3月10日美股成交额前20:HIMS与诺和诺德达成合作,股价大涨逾40%
环球市场播报 · 03-10
3月10日美股成交额前20:HIMS与诺和诺德达成合作,股价大涨逾40%
分析师:Hims & Hers本身不会通过诺和诺德的GLP-1s药物盈利
格隆汇 · 03-09
分析师:Hims & Hers本身不会通过诺和诺德的GLP-1s药物盈利
加载更多
公司概况
公司名称:
Hims & Hers Health Inc.
所属市场:
NYSE
上市日期:
--
主营业务:
Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。
发行价格:
--
{"stockData":{"symbol":"HIMS","market":"US","secType":"STK","nameCN":"Hims & Hers Health Inc.","latestPrice":18.78,"timestamp":1774900800000,"preClose":19.38,"halted":0,"volume":19052303,"hourTrading":{"tag":"盘后","latestPrice":18.7709,"preClose":18.78,"latestTime":"16:14 EDT","volume":245433,"amount":4609456.556628,"timestamp":1774901655174,"change":-0.0091,"changeRate":-0.000485,"amplitude":0.006821},"delay":0,"changeRate":-0.030959752321981317,"floatShares":197512273,"shares":227648514,"eps":0.512286,"marketStatus":"盘后交易","change":-0.6,"latestTime":"03-30 16:14:21 EDT","open":19.35,"high":19.67,"low":18.62,"amount":362891006.157482,"amplitude":0.05418,"askPrice":18.81,"askSize":4,"bidPrice":18.71,"bidSize":3,"shortable":3,"etf":0,"ttmEps":0.512286,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774915200000},"marketStatusCode":4,"adr":0,"exchange":"NYSE","adjPreClose":19.38,"preHourTrading":{"tag":"盘前","latestPrice":19.3524,"preClose":19.38,"latestTime":"09:29 EDT","volume":159515,"amount":3087696.921215,"timestamp":1774877389051,"change":-0.0276,"changeRate":-0.001424,"amplitude":0.02259},"postHourTrading":{"tag":"盘后","latestPrice":18.7709,"preClose":18.78,"latestTime":"16:14 EDT","volume":245433,"amount":4609456.556628,"timestamp":1774901655174,"change":-0.0091,"changeRate":-0.000485,"amplitude":0.006821},"volumeRatio":0.815759,"optionData":{"bulkOrders":[{"symbol":"HIMS","call":true,"expireDate":1775102400000,"strike":"23.5","timestamp":1774897619399,"price":0.02,"volume":2000,"amount":4000,"type":"-"},{"symbol":"HIMS","call":true,"expireDate":1775102400000,"strike":"22.0","timestamp":1774897619399,"price":0.05,"volume":2000,"amount":10000,"type":"+"}]},"impliedVol":1.0045,"impliedVolPercentile":0.5219},"requestUrl":"/m/hq/s/HIMS","defaultTab":"news","newsList":[{"id":"1182181386","title":"Hims & Hers平台扩容:将引入Wegovy与Ozempic减重药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1182181386","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182181386?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:52","pubTimestamp":1773838324,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health Inc.宣布,其服务平台将扩大产品范围,纳入诺和诺德旗下的Wegovy口服片剂与注射剂,以及Ozempic注射剂。这两款药物均属于GLP-1受体激动剂,主要用于体重管理与2型糖尿病治疗。此次引入Wegovy与Ozempic,标志着Hims & Hers正式切入规模快速扩张的GLP-1减重药物市场。Hims & Hers此前主要提供毛发护理、皮肤健康与心理健康服务,此次拓展是其向慢病管理领域迈出的重要一步。消息公布后,Hims & Hers股价在盘前交易中小幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMS","HIMZ","HIMY","BK4196","HMYY"],"gpt_icon":1},{"id":"2618138250","title":"Hims & Hers Health(HIMS)盘前涨8% 日前与诺和诺德建立新的合作伙伴关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2618138250","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618138250?lang=zh_cn&edition=full","pubTime":"2026-03-12 18:08","pubTimestamp":1773310089,"startTime":"0","endTime":"0","summary":"金吾财讯 | Hims & Hers Health 盘前涨8%,截至发稿,报27.950美元。消息面上,日前,Hims & Hers Health与诺和诺德建立新的合作伙伴关系,专注于提供品牌药物。两家公司于周一表示,诺和诺德已同意在Hims & Hers Health平台上销售其王牌药物Ozempic和Wegovy,其中包括备受欢迎的Wegovy口服片剂。同时,诺和诺德将撤回上个月针对Hims & Hers Health提起的诉讼。作为回报,Hims & Hers Health表示将不再为其仿制版诺和诺德药物投放广告。但如果医生认为患者有必要使用,该公司仍将销售Wegovy和Ozempic的复配版本。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/ZTgzYzFjMzMwYjg4MjEzNTY0MzUzNDIy.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZTgzYzFjMzMwYjg4MjEzNTY0MzUzNDIy.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"297963","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","HIMS","HIMZ","LU0154236417.USD","IE00BKVL7J92.USD","HIMY","HIYY","BK4196","IE00BZ1G4Q59.USD","BK4599","BK4585","HMYY","BK4532","BK4007","NVOX","LU1093756168.USD","NVOH","LU1093756325.SGD"],"gpt_icon":0},{"id":"1106846919","title":"盘前异动 | 石油股上涨,Battalion Oil涨近8%;HIMS续涨逾5%,本田汽车跌超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1106846919","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106846919?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:07","pubTimestamp":1773302874,"startTime":"0","endTime":"0","summary":"3月12日,美股三大股指期货下跌,截止发稿,道指期货跌0.60%,纳指期货跌0.45%,标普500指数期货跌0.48%。部分石油股盘前上涨,$Battalion Oil(BATL)$涨近8%,$美国能源(USEG)$涨近5%;$Hims & Hers Health(HIMS)$续涨逾5%,本周三个交易日已累涨约64%。部分加密货币概念股盘前下跌,$BitMine Immersion(BMNR)$跌超4%,$Coinbase(COIN)$、$Robinhood(HOOD)$跌超1%。本田汽车盘前跌超8%,因重新考虑其电车战略而计提高达约157亿美元的费用。 ","market":"us","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e4d6689b7a260553016615cecc1fd48b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","BK4196","BK4555","HMC","BK4585","BK4588","HMYY","HIYY","TEAM","XOP","BMBL","XLE","BK4099","BATL","HIMS","HIMZ","BK4570"],"gpt_icon":0},{"id":"1133915962","title":"异动解读 | 与诺和诺德达成合作并获诉讼和解,Hims & Hers盘前大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133915962","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133915962?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:05","pubTimestamp":1773302710,"startTime":"0","endTime":"0","summary":"远程医疗平台Hims & Hers Health Inc.今日盘前股价大涨5.33%,引起了市场的广泛关注。消息面上,公司近期宣布了两项重要进展。首先,已与制药巨头诺和诺德达成新的合作伙伴关系,将在其平台上销售Ozempic和Wegovy等品牌药物,同时诺和诺德同意撤回此前对Hims & Hers Health提起的诉讼。其次,公司为推进战略转型,已聘请曾在礼来负责公司传播事务的资深公关人士担任首席传播官。这些举措被视为公司从销售仿制药转向专注于提供品牌药物战略转型的重要一步,显著增强了市场对其在快速增长减肥药市场前景的信心,从而推动了股价的上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"1191311809","title":"异动解读 | 与诺和诺德达成合作并获诉讼和解,Hims & Hers夜盘大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191311809","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191311809?lang=zh_cn&edition=full","pubTime":"2026-03-12 14:37","pubTimestamp":1773297426,"startTime":"0","endTime":"0","summary":"远程医疗平台Hims & Hers Health Inc.(HIMS)今日夜盘股价大涨5.02%,引起了市场的广泛关注。消息面上,公司近期宣布了两项重要进展。首先,已与制药巨头诺和诺德达成新的合作伙伴关系,同时诺和诺德同意撤回此前对Hims & Hers Health提起的诉讼;其次,公司为推进战略转型,已聘请曾在礼来负责公司传播事务长达五年的资深公关人士担任首席传播官。这些举措被视为公司从销售仿制药转向专注于提供品牌药物战略转型的重要一步,增强了市场对其在快速增长减肥药市场前景的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"1197495715","title":"期权大单|甲骨文绩后飙升逾9%,期权成交量激增;利好叠加!Hims & Hers三日累涨逾64%,期权交投持续火热","url":"https://stock-news.laohu8.com/highlight/detail?id=1197495715","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197495715?lang=zh_cn&edition=full","pubTime":"2026-03-12 10:18","pubTimestamp":1773281880,"startTime":"0","endTime":"0","summary":"周三,期权市场总成交量5222.08万张合约,低于90日均量;甲骨文当日期权成交113.26万张,较90日均量放大逾3倍;Hims & Hers Health当日成交55.81万张,看涨期权占比61.1%>>一、市场概览 美东时间周三,美股三大指数涨跌互现,投资者持续关注美伊冲突局势以及油价走势。期权方面,Hims & Hers Health当日成交55.81万张,较90日均量放大近4倍,看涨期权占比61.1%,其中于3月13日到期的30美元行使价的看涨期权成交居前,成交超3.3万张。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","ORCL"],"gpt_icon":1},{"id":"1136670187","title":"夜盘异动|石油股走高,INDO大涨超14%,HIMS续涨1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136670187","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136670187?lang=zh_cn&edition=full","pubTime":"2026-03-12 08:43","pubTimestamp":1773276230,"startTime":"0","endTime":"0","summary":"伊拉克石油港口已停止运营。","market":"us","thumbnail":"https://static.tigerbbs.com/cdc7ca9eb3fdcde7868d42c981e73b12","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cdc7ca9eb3fdcde7868d42c981e73b12"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"55b45ec12279d21b7514d451b01df448","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDO","HIMS","BATL"],"gpt_icon":0},{"id":"1117396924","title":"异动解读 | Hims & Hers Health盘中大涨5.16%,与诺和诺德达成合作并挖角礼来公关大将","url":"https://stock-news.laohu8.com/highlight/detail?id=1117396924","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117396924?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:41","pubTimestamp":1773236517,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health Inc.今日盘中股价大幅上涨5.16%,引起了市场的广泛关注。消息面上,公司近期宣布了两项重要进展。首先,Hims & Hers Health已与制药巨头诺和诺德达成新的合作伙伴关系,将在其平台上销售诺和诺德的王牌品牌减肥药Ozempic和Wegovy,其中包括备受欢迎的Wegovy口服片剂。同时,诺和诺德同意撤回此前对Hims & Hers Health提起的诉讼,标志着双方持续数月的法律争执得到解决。作为协议的一部分,Hims & Hers Health将不再为其仿制版诺和诺德药物投放广告。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":1},{"id":"2618918759","title":"Hims & Hers(HIMS.US)挖角礼来公关大将!剑指品牌减肥药新战场","url":"https://stock-news.laohu8.com/highlight/detail?id=2618918759","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618918759?lang=zh_cn&edition=full","pubTime":"2026-03-11 10:22","pubTimestamp":1773195738,"startTime":"0","endTime":"0","summary":"此前,Hims & Hers HealthHims因销售热门减肥药的仿制版本而面临日益增加的法律和监管压力。Hims & Hers Health表示,公司将通过与礼来的主要竞争对手诺和诺德建立新的合作伙伴关系,专注于提供品牌药物。两家公司于周一表示,诺和诺德已同意在Hims & Hers Health平台上销售其王牌药物Ozempic和Wegovy,其中包括备受欢迎的Wegovy口服片剂。同时,诺和诺德将撤回上个月针对Hims & Hers Health提起的诉讼。作为回报,Hims & Hers Health表示将不再为其仿制版诺和诺德药物投放广告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2111349929.HKD","LU0385154629.USD","LU0320765059.SGD","LU1804176565.USD","LU0203202063.USD","LU2089284900.SGD","LU0353189680.USD","LU0320765992.SGD","LU2361045086.USD","LU0943347566.SGD","LU2491050071.SGD","IE00B4R5TH58.HKD","LU2168564495.EUR","SG9999014898.SGD","LU0708995401.HKD","LU2168564222.USD","IE00BWXC8680.SGD","LU0471298694.HKD","LU0823416689.USD","LU1814569148.SGD","LU0882574139.USD","IE0001KFT4U8.USD","LU2063271972.USD","LU2108987350.USD","LU1720051017.SGD","LU0316494557.USD","LU1623119135.USD","IE00BFSS7M15.SGD","IE00BJT1NW94.SGD","LU2237443382.USD","IE00BN29S564.USD","LU2265009873.SGD","LU0823434583.USD","LU0094547139.USD","LU2213496289.HKD","BK4534","LU1291159041.SGD","SGXZ99366536.SGD","BK4585","LU0158827948.USD","LU0256863811.USD","LU1093756325.SGD","SG9999001176.USD","LU2087625088.SGD","LU0471298777.SGD","LU0114720955.EUR","LU0786609619.USD","SG9999015945.SGD","LU2168563687.JPY","SG9999014880.SGD","LU2471134523.USD","LU1629891620.HKD","LU1551013425.SGD","LU0289739699.SGD","LU0787776722.HKD","LU1093756168.USD","LU1720051108.HKD","LU0640476718.USD","LU2089283258.USD","LU2237443622.USD","LU2360106947.USD","LU0689472784.USD","IE00BFTCPJ56.SGD","IE00BKPKM429.USD","LU1551013342.USD","HMYY","IE00BK4W5L77.USD","IE00BK4W5M84.HKD","LU1057294990.SGD","LU2471134796.USD","IE00BJJMRY28.SGD","BK4588","LU1023059063.AUD","LU2456880835.USD","LU0354030438.USD","LU1323610961.USD","LU0158827781.USD","LU2237443895.HKD","LU2361044865.SGD","LU2237443978.SGD","LU0210536198.USD","LU0266013472.USD","LLYX","LU0417517546.SGD","LU1989771016.USD","LU2491049909.HKD","IE00B7KXQ091.USD","LU2552382132.HKD","LU1061106388.HKD","HIYY","LU2168564065.EUR","LU2361044949.HKD","LU2746668974.SGD","LU1983299246.USD","SGXZ31699556.SGD","LU0006306889.USD","LU2106854487.HKD","LU0122379950.USD","SGXZ81514606.USD","LU0234572021.USD","SG9999001176.SGD","LU0823434740.USD","LLII","HIMZ","SG9999015986.USD","IE00B1XK9C88.USD","LU0109394709.USD","LU0432979614.USD","LU2896262040.SGD","LU1868836914.USD","ELIS","LU1069344957.HKD","LU2462157665.USD","LU0061475181.USD","SG9999015978.USD","LU0820562030.AUD","LU2552382058.USD","LU2168564149.EUR","LU2756315318.SGD","BK4516","LU0820561909.HKD","LU0889565916.HKD","LU0225283273.USD","LU2237443549.SGD","LU0079474960.USD","HIMS","LU0106261372.USD","LU1868836591.USD","LU1548497426.USD","LU1232071149.USD","LU1366192091.USD","LU2211815571.USD","SGXZ51526630.SGD","LU2461242641.AUD","LU2468319806.SGD","LU2756315664.SGD","BK4581","LU1145028129.USD","BK4533","BK4007","LU1868837136.USD","SG9999014906.USD","ELIL","IE00B775H168.HKD","LU2746668461.USD","LU1267930730.SGD","IE00BJJMRZ35.SGD","IE00BKDWB100.SGD","LU1127390331.HKD","SGXZ57979304.SGD","LU0096364046.USD","LU2112291526.USD","LU0323591593.USD","LU1712237335.SGD","LU1917777945.USD","LU2750360641.GBP","LU2237443465.HKD","LU2491050154.USD","IE0002141913.USD","LU2023251221.USD","SG9999014914.USD","LU2471134879.HKD","IE00B2B36J28.USD","IE00B1BXHZ80.USD","LU0238689110.USD","BK4196","LU0354030511.USD","LU2023250504.SGD","SG9999017495.SGD","SG9999018857.SGD","LU0058720904.USD","SG9999018865.SGD","LU1974910355.USD","LU0683600562.USD","SG9999013999.USD","LU0456855351.SGD","LU2602419157.SGD","IE0004445239.USD","LU0109391861.USD","LU0672654240.SGD","BK4599","LU1988902786.USD","IE00B4JS1V06.HKD","LU2357305700.SGD","GB00BDT5M118.USD","LU0353189763.USD","LU1280957306.USD","LU2417539215.USD","LU2089984988.USD","LU2471134952.CNY","LU0097036916.USD","HIMY","LU2028103732.USD","IE00BJJMRX11.SGD","LU1868837300.USD","LU2750360997.AUD","LU1035775433.USD","SG9999015952.SGD","LU0203201768.USD","LU0964807845.USD","LU2264538146.SGD","LU2236285917.USD","LU0256863902.USD","IE0005OL40V9.USD","LU2324357040.USD","IE00BJLML261.HKD","LU2552382215.SGD","LU1868836757.USD","LU0882574055.USD","IE0004445015.USD","LU2237438978.USD","LLYZ","LU2271345857.HKD","LU0466842654.USD","IE0009355771.USD","LU2023250330.USD","LU0820561818.USD","LU1064131342.USD","IE00BFSS8Q28.SGD","LU0198837287.USD"],"gpt_icon":1},{"id":"1120606316","title":"异动解读 | Hims & Hers Health盘中大涨13.37%,与诺和诺德达成合作协议并获花旗上调评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1120606316","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120606316?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:36","pubTimestamp":1773149804,"startTime":"0","endTime":"0","summary":"远程医疗服务公司Hims & Hers Health Inc.今日盘中股价大涨13.37%,引起了市场的广泛关注。根据协议,诺和诺德将通过Hims & Hers的平台销售其广受欢迎的GLP-1减肥药物,包括Ozempic和Wegovy。作为合作的一部分,诺和诺德已同意撤回此前对Hims & Hers提起的专利侵权诉讼,标志着双方从法律争端转向商业伙伴关系。此项合作显著降低了Hims & Hers此前面临的业务风险,包括产品管线单一性和合规不确定性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"05b47021c469e7d3f1884b07d446c55d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":1},{"id":"2618895342","title":"Hims & Hers与诺和诺德达成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2618895342","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618895342?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:03","pubTimestamp":1773147780,"startTime":"0","endTime":"0","summary":"Hims & Hers与诺和诺德结束诉讼,Hims将停止推广复方胰高血糖素样肽-1药物,并通过其平台提供威戈维和奥泽匹克;Hims股价大涨。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:张俊 SF065","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-10/doc-inhqphnh6182604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","HIMS","LU0154236417.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVO","BK4599","BK4585","BK4532","BK4007","NVOX","LU1093756168.USD","NVOH","LU1093756325.SGD"],"gpt_icon":0},{"id":"1126668487","title":"花旗集团上调Hims & Hers Health Inc评级至中性,目标价大幅提升至24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126668487","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126668487?lang=zh_cn&edition=full","pubTime":"2026-03-10 18:27","pubTimestamp":1773138443,"startTime":"0","endTime":"0","summary":"花旗集团最新发布的研究报告显示,已将对远程医疗公司Hims & Hers Health Inc的股票评级从\"卖出\"上调至\"中性\"。与此同时,该机构将其目标股价从13.25美元显著调高至24美元,涨幅超过80%。\n此次评级调整反映了花旗对该公司业务发展前景的重新评估。目标价的大幅提升可能基于对公司营收增长、市场份额扩大或盈利能力改善的积极预期。作为专注于男性与女性健康领域的远程医疗服务商,Hims & Hers Health Inc近期在扩大用户基础和优化服务模式方面取得进展,这或是引发机构重新评估其价值的关键因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"05b47021c469e7d3f1884b07d446c55d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HMYY","BK4196","HIMS","HIMZ","HIYY"],"gpt_icon":0},{"id":"1129529872","title":"异动解读 | 与诺和诺德达成合作协议,Hims & Hers Health盘前大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129529872","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129529872?lang=zh_cn&edition=full","pubTime":"2026-03-10 18:20","pubTimestamp":1773138049,"startTime":"0","endTime":"0","summary":"远程医疗服务公司Hims & Hers Health Inc.今日盘前股价大幅上涨5.14%,引起了市场的广泛关注。根据协议,诺和诺德将通过Hims & Hers的平台销售其广受欢迎的GLP-1减肥药物,包括Ozempic和Wegovy。作为合作的一部分,诺和诺德已同意撤回此前对Hims & Hers提起的专利侵权诉讼,标志着双方从法律争端转向商业伙伴关系。市场分析认为,此项合作显著降低了Hims & Hers此前面临的业务风险,包括产品管线单一性和合规不确定性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"1189008764","title":"盘前异动 | 光通信股续涨,Coherent涨近4%; 福泰制药涨超5%,无人机概念股JOBY涨近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189008764","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189008764?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:09","pubTimestamp":1773130152,"startTime":"0","endTime":"0","summary":"3月10日,美股三大股指期货上涨,截止发稿,道指期货涨0.30%,纳指期货涨0.35%,标普500指数期货涨0.29%。加密货币概念股盘前普涨,$Coinbase$、$Circle$、$Strategy$涨超2%,$Robinhood$、$BitMine Immersion$等跟涨。存储概念股上涨,闪迪涨超2%,$美光科技$、$西部数据$、希捷科技涨超1%。美股光通信股盘前续涨,Coherent、Lumentum、$Applied Optoelectronics$均涨近4%;无人机概念股$Joby Aviation$涨近5%,宣布成为美国空中出租车试点项目合作伙伴。慧与科技涨超2%,2026财年Q1营收同比增长18%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","DOT.USD.CC","LU1861217088.USD","LITE","BK4023","BK4596","BK4600","BK4516","BK4554","LU1861220207.SGD","COMP.USD.CC","BK4551","UNI.USD.HKCC","BK4535","BK4595","BK4601","APT.USD.HKCC","VRTX","SNDK","LU1861559042.SGD","MKR.USD.CC","SNX.USD.CC","TON.USD.CC","UNI.USD.CC","APT.USD.CC","HPE","BK4588","LU2360107671.USD","AVAX.USD.CC","COIN","COHR","BK4539","LU1861558580.USD","USDT.USD.CC","BK4594","LINK.USD.HKCC","BK4585","TON.USD.HKCC","AVAX.USD.HKCC","HIMS","LTC.USD.HKCC"],"gpt_icon":0},{"id":"2618147987","title":"花旗上调Hims & Hers Health(HIMS.US)评级至“中性” 看好诺和诺德协议下的合规溢价","url":"https://stock-news.laohu8.com/highlight/detail?id=2618147987","media":"智通财经","labels":["executive","rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618147987?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:07","pubTimestamp":1773130046,"startTime":"0","endTime":"0","summary":"花旗银行在最新的研究报告中对这一合作给予了高度评价,并将其视为 Hims & Hers 发展史上的重要转折点。花旗分析师指出,通过引入官方正版药物,Hims & Hers 成功摆脱了长期困扰其业务模式的合规性阴影与法律风险。这一利好消息在二级市场引发了剧烈反弹,Hims & Hers 的股价在消息公布后的交易时段内一度飙升超过 35%,周一收涨40.79%,报22.16美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":"5cccc8ba7a9e8bd0cd40ca1f6c5f84c3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,rating","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4504","BK4532","LU0098860793.USD","LU1244550221.USD","BK4566","HIMZ","LU2456880835.USD","BK4585","LU0314106906.USD","LU1506573853.SGD","LU1162221912.USD","LU1093756325.SGD","LU0310800965.SGD","NVOX","HMYY","LU0130517989.USD","LU0154236417.USD","LU1366192091.USD","BK4007","LU2125154778.USD","IE00BSNM7G36.USD","BK4196","LU0648001328.SGD","IE00BZ1G4Q59.USD","LU1668664300.SGD","LU0170899867.USD","LU1244550494.USD","LU2417539215.USD","LU1267930227.SGD","LU0072461881.USD","LU2125154935.USD","LU1201861249.SGD","BK4559","IE00BKVL7J92.USD","LU0980610538.SGD","BK4588","LU2236285917.USD","LU0130102774.USD","LU0477156953.USD","LU0052756011.USD","BK4599","LU0320765646.SGD","LU2462157665.USD","LU0106831901.USD","BK4207","LU2360032135.SGD","NVOH","LU1244550577.SGD","LU0128525689.USD","LU0162691827.USD","HIMY","LU1093756168.USD","BK4534","LU1791807156.HKD","HIYY","HIMS"],"gpt_icon":1},{"id":"1177597123","title":"ETF日报|2倍做多Hims & Hers ETF涨超81%;三倍做多半导体ETF涨超11%;成长风格领跑","url":"https://stock-news.laohu8.com/highlight/detail?id=1177597123","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177597123?lang=zh_cn&edition=full","pubTime":"2026-03-10 10:30","pubTimestamp":1773109800,"startTime":"0","endTime":"0","summary":"大宗商品中,白银相关ETF显著走强,原油做多品种回落。该产品两倍做多在线医疗平台公司$Hims & Hers Health$,因底层公司股价上涨,杠杆机制放大当日涨幅。$诺和诺德$计划在Hims & Hers Health平台销售减重药物,双方结束此前的法律纠纷,公司股价大幅上涨。该产品围绕Hims & Hers Health开展期权收益策略,因公司股价上行,份额净值同步走高。$2倍做多恐慌指数期货ETF$下跌19.40%。行业指数ETF涨幅Top 5$三倍做多半导体ETF-Direxion Daily$上涨11.34%。债券ETF涨幅Top 5$First Trust SSI Strategic Convertible Securities ETF$上涨2.02%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6ff7c068e21399ce793d8151cce49f41","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGQ","IBB","LU0823414478.USD","HIMZ","CRCD","LU2264538146.SGD","HIYY","BMNR","LU0444971666.USD","SOXL","CRCL","SLV","CWB","LU2294711713.HKD","BEZ","LU0444973449.USD","RCAX","LU2506951792.HKD","BK4541","LU1988902786.USD","LU1064131342.USD","UVIX","RDWU","DGZ","NLR","YINN","HIMS","FCVT","ICVT","LU0476273544.USD","LU0957808578.USD","NUGT","OIH","TUR","BK4588","LU0823414551.USD","LU1815336760.USD","EWY","XLK","VCLT","BK4550","TQQQ","BE","LU2543165471.USD","BMNZ","SPLB","LU2357125470.USD","LITE","LU1642822529.SGD","BK4585","LU2249611893.SGD","RDW","BEG","SMH","BK4182","EDC","LITX"],"gpt_icon":1},{"id":"1102310758","title":"期权大单|半导体板块全线反弹!英伟达看涨期权遭抢筹;Hims & Hers股价飙升逾40%,Call单最高涨84倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1102310758","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102310758?lang=zh_cn&edition=full","pubTime":"2026-03-10 10:00","pubTimestamp":1773108000,"startTime":"0","endTime":"0","summary":"期权方面,Hims & Hers当日成交57.39万张,较90日均量放大逾4倍,看涨期权占比攀升至67.6%,其中于3月13日到期的25美元行使价的看涨期权成交居前,成交近2.2万张;此外,从期权链上看,Hims & Hers多张Call单翻倍大涨,最高飙涨8400%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","NVDA"],"gpt_icon":1},{"id":"1139774313","title":"异动解读 | 与诺和诺德达成合作协议,Hims & Hers Health夜盘大涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139774313","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139774313?lang=zh_cn&edition=full","pubTime":"2026-03-10 08:02","pubTimestamp":1773100967,"startTime":"0","endTime":"0","summary":"远程医疗服务公司Hims & Hers Health Inc.今日夜盘大幅上涨5.64%,引起了市场的广泛关注。消息面上,该公司与丹麦制药巨头诺和诺德达成了一项重要的合作协议。根据协议,诺和诺德将通过Hims & Hers的平台销售其明星减肥药物Wegovy和Ozempic,这标志着双方从法律纠纷转向商业合作。作为协议的一部分,诺和诺德同意撤回此前对Hims & Hers提起的专利侵权诉讼。同时,Hims & Hers承诺将停止宣传其仿制的GLP-1减肥药物,仅在医生认为有临床必要时才提供复合制剂。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5cccc8ba7a9e8bd0cd40ca1f6c5f84c3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"2618672446","title":"3月10日美股成交额前20:HIMS与诺和诺德达成合作,股价大涨逾40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618672446","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618672446?lang=zh_cn&edition=full","pubTime":"2026-03-10 04:48","pubTimestamp":1773089280,"startTime":"0","endTime":"0","summary":"周一美股成交额第1名英伟达收高2.72%,成交313.6亿美元。亿万富豪廖凯原周一再度增持英伟达,将其持股数量翻倍至200万股。 摩尔维持对博通的“买入”评级,将其目标价从462美元上调至470美元,意味着约42%的上涨空间。 此外,3月2日,英伟达宣布投资20亿美元并与Lumentum达成多年战略合作,包括数十亿美元采购高端激光元件的承诺,聚焦AI数据中心光学技术。 该消息公布后,诺和诺德撤销了对该公司的诉讼,标志着双方争端的结束。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2125f643a531f294312a5aa84a9983ad","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-10/doc-inhqmumf6558599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVO","LU0154236417.USD","BK4007","HMYY","IE00BKVL7J92.USD","HIYY","BK4532","NVOH","BK4585","NVOX","HIMZ","HIMY","BK4196","IE00BZ1G4Q59.USD","BK4599","BK4588","HIMS","LU1093756325.SGD","LU1093756168.USD"],"gpt_icon":1},{"id":"2618621200","title":"分析师:Hims & Hers本身不会通过诺和诺德的GLP-1s药物盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2618621200","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618621200?lang=zh_cn&edition=full","pubTime":"2026-03-09 21:43","pubTimestamp":1773063796,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1093756168.USD","BK4585","BK4144","BK4599","LU0154236417.USD","BK4007","NVOX","BK4590","LU1093756325.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4588","HIMS","BK4532","NVOH"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1199},{"period":"1month","weight":0.225},{"period":"3month","weight":-0.4352},{"period":"6month","weight":-0.6682},{"period":"1year","weight":-0.3929},{"period":"ytd","weight":-0.4031}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0852},{"period":"3month","weight":-0.0814},{"period":"6month","weight":-0.0419},{"period":"1year","weight":0.1182},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.098962},{"month":2,"riseRate":0.571429,"avgChangeRate":0.066017},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.002576},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.029824},{"month":5,"riseRate":0.5,"avgChangeRate":0.191652},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.021115},{"month":7,"riseRate":0.666667,"avgChangeRate":0.073238},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.14623},{"month":9,"riseRate":0.5,"avgChangeRate":0.080437},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.073266},{"month":11,"riseRate":0.714286,"avgChangeRate":0.187933},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.001486}],"exchange":"NYSE","name":"Hims & Hers Health Inc.","nameEN":"Hims & Hers Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Hims & Hers Health Inc.,HIMS,Hims & Hers Health Inc.股票,Hims & Hers Health Inc.股票老虎,Hims & Hers Health Inc.股票老虎国际,Hims & Hers Health Inc.行情,Hims & Hers Health Inc.股票行情,Hims & Hers Health Inc.股价,Hims & Hers Health Inc.股市,Hims & Hers Health Inc.股票价格,Hims & Hers Health Inc.股票交易,Hims & Hers Health Inc.股票购买,Hims & Hers Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}